{"id":"W4281848556","doi":"10.1016/j.jacl.2022.05.067","title":"Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT","year":2022,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"St. Jude Medical; Esperion Therapeutics; HLS Therapeutics; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Servier; Assistance publique-Hôpitaux de Paris; Pfizer; Moderna; Medicines Company; Regado Biosciences; Belvoir Media Group; MyoKardia; Novo Nordisk; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Duke Clinical Research Institute; Eisai; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; CSL Behring; Novartis; Amgen; Sanofi; American Heart Association","keywords":"Medicine; Residual risk; Hypertriglyceridemia; Myocardial infarction; Internal medicine; Cardiology; Revascularization; Clinical endpoint; Randomized controlled trial; Stroke (engine); Triglyceride; Cholesterol","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0306632,0.0005166136,0.01461414,0.0003758988,0.000103156,0.000006606098,0.0006059795,0.0009444466,0.0005889962],"category_scores_gemma":[0.01772662,0.0003864102,0.01535566,0.0005110426,0.0002371302,0.00007455081,0.0002328612,0.003009069,0.000005800688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002054496,"about_ca_system_score_gemma":0.003505307,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001059393,"about_ca_topic_score_gemma":0.000006070637,"domain_scores_codex":[0.984036,0.004049352,0.009117743,0.0007121955,0.001635757,0.0004489277],"domain_scores_gemma":[0.9862213,0.003573193,0.007255232,0.001566016,0.0009756461,0.0004085976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004269998,0.0003249602,0.00001311833,0.09164771,0.01127117,0.00001457455,0.00005528171,0.000008031359,9.003547e-7,0.00002669955,0.008365293,0.8878453],"study_design_scores_gemma":[0.002229529,0.002780412,0.0001088717,0.1018679,0.02920836,0.001260949,0.00005525996,1.717006e-7,0.00001840744,0.00005133805,0.8621882,0.0002305106],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000679876,0.9886692,0.0001922837,0.0006516681,0.007344947,0.002123465,0.0002406752,0.000009155202,0.00008875705],"genre_scores_gemma":[0.00001989084,0.9774085,0.005497266,0.0002825983,0.01642085,0.00009341673,0.0001217919,0.00009220772,0.00006344436],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8876147,"threshold_uncertainty_score":0.9998588,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1941017303857026,"score_gpt":0.4499473697340759,"score_spread":0.2558456393483733,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}